En 2017, Mundo Sano se alió con EDCTP para financiar conjuntamente ensayos clínicos de herramientas innovadoras destinadas a enfermedades infecciosas desatendidas. De esta iniciativa surgieron los proyectos STOP 1 y 2, que llevaron a cabo el ensayo clínico (fase 2/3) que ha sustentado el dossier enviado a EMA. También son la base del proyecto STOP2030, del que forma parte Mundo Sano y que busca generar nuevas evidencias sobre seguridad en grandes poblaciones, coste eficiencia y aceptabilidad.
- Inglés
- The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive scientific opinion for the fixed-dose combination (FDC) of albendazole and ivermectin for the treatment of soil-transmitted helminths (STH) and lymphatic filariasis (LF). This marks a significant milestone for this pharmacological tool and brings it closer to its mass adoption by endemic countries.
- The FDC combines two antiparasitic drugs, albendazole and ivermectin, in a fixed-dose tablet thought from the beginning with a public . It maintains the simple logistics of the one-pill-per-person mass drug administration campaigns while controlling more species of parasites.
- The FDC combines two antiparasitic drugs, albendazole and ivermectin, in a fixed-dose tablet thought from the beginning with its public health in mind. It maintains the simple logistics of the one-pill-per-person mass drug administration campaigns while controlling more species of parasites.
borja
2 months ago